Skip to main content

Anixa Biosciences, Inc. (ANIX)

NASDAQ: ANIX · IEX Real-Time Price · USD
4.89 -0.11 (-2.20%)
Sep 24, 2021 4:00 PM EDT - Market closed
Market Cap146.46M
Revenue (ttm)512,500
Net Income (ttm)-11.17M
Shares Out30.46M
EPS (ttm)-0.41
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume85,116
Open4.95
Previous Close5.00
Day's Range4.86 - 5.10
52-Week Range1.91 - 8.09
Beta1.49
AnalystsStrong Buy
Price Target11.00 (+124.9%)
Est. Earnings Daten/a

About ANIX

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain viral protein functions of the virus. Its vaccine...

IndustryBiotechnology
IPO DateJan 1, 1987
CEOAmit Kumar
Employees3
Stock ExchangeNASDAQ
Ticker SymbolANIX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for ANIX stock is "Strong Buy." The 12-month stock price forecast is 11.00, which is an increase of 124.95% from the latest price.

Price Target
$11.00
(124.95% upside)
Analyst Consensus: Strong Buy

News

Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for Ovarian C...

SAN JOSE, Calif., Sept. 14, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced toda...

1 week ago - PRNewsWire

Anixa Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

SAN JOSE, Calif., Sept. 8, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today...

2 weeks ago - PRNewsWire

Anixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer

SAN JOSE, Calif., Sept. 7, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today...

2 weeks ago - PRNewsWire

Anixa (ANIX) Ovarian Cancer CAR-T Drug to Enter Clinical Study

The FDA clears Anixa Biosciences' (ANIX) application to initiate clinical studies for its ovarian cancer CAR-T therapy. The stock rises following the announcement.

3 weeks ago - Zacks Investment Research

Anixa Biosciences' CAR-T Therapy To Start Human Trial For Ovarian Cancer

The FDA has signed off Anixa Biosciences Inc's (NASDAQ: ANIX) application for its CAR-T (Chimeric Antigen Receptor-T cell) therapy, developed in partnership with Moffitt Cancer Center. Anixa Biosciences...

3 weeks ago - Benzinga

Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer CAR-T...

SAN JOSE, Calif., Aug. 30, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today...

3 weeks ago - PRNewsWire

Anixa Biosciences' COVID-19 Compounds Show Potential Efficacy Against Delta Variant

Anixa Biosciences Inc (NASDAQ: ANIX) has announced that a genomic variant analysis indicates that its potential compounds may be more effective against the Delta variant than the original wild-type SARS...

1 month ago - Benzinga

Anixa Biosciences' Covid-19 Compounds Expected to be Effective Against the Delta Variant

SAN JOSE, Calif., Aug. 25, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today...

1 month ago - PRNewsWire

Anixa Biosciences Congratulates Director, Dr. Arnold Baskies for His Appointment to the WHO's Global Breast Cancer In...

SAN JOSE, Calif., Aug. 23, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today...

1 month ago - PRNewsWire

Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology

SAN JOSE, Calif., Aug. 18, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today...

1 month ago - PRNewsWire

Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Clevel...

SAN JOSE, Calif., May 26, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today ...

4 months ago - PRNewsWire

Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application

SAN JOSE, Calif., May 20, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today ...

4 months ago - PRNewsWire

OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie

HALLE (SAALE), Germany, May 7, 2021 /PRNewswire/ -- OntoChem GmbH, a German Life Science IT company, announced today that it has assigned its drug discovery technologies and assets, including its drug d...

4 months ago - PRNewsWire

Anixa's Stock Craters As FDA Slaps Clinical Hold On CAR-T Program

Anixa Biosciences Inc (NASDAQ: ANIX) shares drop after the FDA has requested additional information on its Chimeric Antigen Receptor-T cell therapy (CAR-T) being developed in partnership with Moffitt Ca...

5 months ago - Benzinga

Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy

SAN JOSE, Calif., April 19, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced toda...

5 months ago - PRNewsWire

Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic

SAN JOSE, Calif., April 5, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today...

5 months ago - PRNewsWire

Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million

SAN JOSE, Calif., March 22, 2021 /PRNewswire/ -- Anixa Biosciences, Inc.  (NASDAQ: ANIX) ("Anixa" or the "Company"), a biotechnology company focused on the treatment and prevention of cancer and infecti...

6 months ago - PRNewsWire

Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock

SAN JOSE, Calif., March 22, 2021 /PRNewswire/ -- Anixa Biosciences, Inc.  (NASDAQ: ANIX) ("Anixa" or the "Company"), a biotechnology company focused on the treatment and prevention of cancer and infecti...

6 months ago - PRNewsWire

Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy

SAN JOSE, Calif., March 22, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced toda...

6 months ago - PRNewsWire

Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology

SAN JOSE, Calif., March 12, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced toda...

6 months ago - PRNewsWire

Anixa Biosciences (ANIX) Catches Eye: Stock Jumps 8.7%

Anixa Biosciences (ANIX) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

9 months ago - Zacks Investment Research

Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office

SAN JOSE, Calif., July 10, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced...

1 year ago - PRNewsWire

Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds

SAN JOSE, Calif., July 6, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced ...

1 year ago - PRNewsWire

Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline

SAN JOSE, Calif., July 2, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced ...

1 year ago - PRNewsWire

Top Ranked Momentum Stocks to Buy for February 11th

Top Ranked Momentum Stocks to Buy for February 11th

Other symbols:ACBIAFG
1 year ago - Zacks Investment Research